Developing a CAR-T for Autoimmune Disease Clinical Program Effectively

Time: 1:00 pm
day: Conference Day Two


  • Discussing background and outcomes using CAR-T cells in hematological malignancies
  • Developing a multidisciplinary program to administer CAR-T cell therapies for noncancer indications
  • Identifying challenges when using CAR-T cells in autoimmune diseases rather than in B-cell malignancies